Drugs / Fluticason
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06482294 | Jun 2024 → May 2025 | asthma | Università degli Studi di Ferrara | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT01240889 Comparator | Nov 2010 → Jul 2011 | allergic disease | Creighton University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluticason | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01240889 ↗ |
| Modality | Other / unclassified | “Nasal steroid” NCT01240889 ↗ |
| Route | Intranasal | “2 sprays per day in each nostril” NCT01240889 ↗ |